528 related articles for article (PubMed ID: 28419126)
21. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
22. Availability, pricing, and affordability of essential medicines for pediatric population in Malawi.
Chiumia FK; Chithope-Mwale C; Abikoloni F; Matchaya V; Gaviyawo T; Khuluza F
Front Pharmacol; 2024; 15():1379250. PubMed ID: 38666031
[TBL] [Abstract][Full Text] [Related]
23. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
24. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
25. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
Yang H; Dib HH; Zhu M; Qi G; Zhang X
Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
[TBL] [Abstract][Full Text] [Related]
26. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
27. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
[TBL] [Abstract][Full Text] [Related]
28. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
29. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
Dong Z; Tao Q; Yan B; Sun G
PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
31. Availability, affordability and costs of pediatric medicines in Mongolia.
Dorj G; Sunderland B; Sanjjav T; Dorj G; Gendenragchaa B
BMC Pediatr; 2018 May; 18(1):149. PubMed ID: 29720129
[TBL] [Abstract][Full Text] [Related]
32. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
33. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y
PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471
[TBL] [Abstract][Full Text] [Related]
34. Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey.
Mohammed SA; Tsehay T; Faris AG; Mengstu G
PLoS One; 2022; 17(12):e0279465. PubMed ID: 36542641
[TBL] [Abstract][Full Text] [Related]
35. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
Tadesse T; Abuye H; Tilahun G
BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
[TBL] [Abstract][Full Text] [Related]
36. Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya.
Ooms GI; van Oirschot J; Okemo D; Waldmann B; Erulu E; Mantel-Teeuwisse AK; van den Ham HA; Reed T
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009702. PubMed ID: 34398889
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
38. Availability, price and affordability of asthma medicines in five Indian states.
Kotwani A
Int J Tuberc Lung Dis; 2009 May; 13(5):574-9. PubMed ID: 19383189
[TBL] [Abstract][Full Text] [Related]
39. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
[TBL] [Abstract][Full Text] [Related]
40. Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia.
Hailu AD; Mohammed SA
BMC Med Inform Decis Mak; 2020 Sep; 20(1):221. PubMed ID: 32917201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
